Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Holmans

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset ADAmanda J Myers, Helen Marshall, Peter Holmans, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 25, 2005
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's diseasePeter Holmans, Marian Hamshere, Paul Hollingworth, et al.
Molecular Psychiatry|November 28, 2013
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophreniaDouglas M Ruderfer, Ayman H Fanous, Stephan Ripke, et al.
Human Molecular Genetics|December 8, 2007
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's diseaseYonghong Li, Andrew Grupe, Charles Rowland, et al.
Human Molecular Genetics|February 24, 2007
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variantsAndrew Grupe, Richard Abraham, Yonghong Li, et al.
Brain : a Journal of Neurology|October 23, 2015
Common polygenic variation enhances risk prediction for Alzheimer's diseaseValentina Escott-Price, Rebecca Sims, Christian Bannister, et al.
Nature Neuroscience|January 15, 2020
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophreniaElliott Rees, Jun Han, Joanne Morgan, et al.
Molecular Psychiatry|September 8, 2019
A polygenic resilience score moderates the genetic risk for schizophreniaJonathan L Hess, Daniel S Tylee, Manuel Mattheisen, et al.
American Journal of Medical Genetics|February 22, 2002
Full genome screen for Alzheimer disease: stage II analysisAmanda Myers, Fabienne Wavrant De-Vrieze, Peter Holmans, et al.
Plos Medicine|October 24, 2012
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisKatherine E Tansey, Michel Guipponi, Nader Perroud, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset ADAmanda J Myers, Helen Marshall, Peter Holmans, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 25, 2005
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's diseasePeter Holmans, Marian Hamshere, Paul Hollingworth, et al.
Molecular Psychiatry|November 28, 2013
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophreniaDouglas M Ruderfer, Ayman H Fanous, Stephan Ripke, et al.
Human Molecular Genetics|December 8, 2007
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's diseaseYonghong Li, Andrew Grupe, Charles Rowland, et al.
Human Molecular Genetics|February 24, 2007
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variantsAndrew Grupe, Richard Abraham, Yonghong Li, et al.
Brain : a Journal of Neurology|October 23, 2015
Common polygenic variation enhances risk prediction for Alzheimer's diseaseValentina Escott-Price, Rebecca Sims, Christian Bannister, et al.
Nature Neuroscience|January 15, 2020
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophreniaElliott Rees, Jun Han, Joanne Morgan, et al.
Molecular Psychiatry|September 8, 2019
A polygenic resilience score moderates the genetic risk for schizophreniaJonathan L Hess, Daniel S Tylee, Manuel Mattheisen, et al.
American Journal of Medical Genetics|February 22, 2002
Full genome screen for Alzheimer disease: stage II analysisAmanda Myers, Fabienne Wavrant De-Vrieze, Peter Holmans, et al.
Plos Medicine|October 24, 2012
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisKatherine E Tansey, Michel Guipponi, Nader Perroud, et al.
Pageof 18